For younger patients suffering from breast cancer, problems with fertility can be particularly concerning. Matteo Lambertini, MD from Institut Jules Bordet, Brussels, Belgium discusses the PREFER trial (NCT02895165), a prospective study which aimed to increase our understanding and improve fertility and pregnancy issues in these patients. Dr Lambertini explains the structure of the study and talks us through their main conclusions. This interview was recorded at the 2017 European Society for Medical Oncology (ESMO) conference held in Madrid, Spain.
